Aqueous humor levels of hepatocyte growth factor in retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 6, 2010, Pages 3157-3161

  Salom, David ^a,b   Diaz Llopis, Manuel ^a,b,c,d   Quijada, Arturo ^c   García Delpech, Salvador ^a,b,c,e   Udaondo, Patricia ^a,b   Javier Romero, F ^d,f   Millan, Jose Maria ^b,e   Fernando Arevalo, J ^g  

^a University Hospital of Valencia   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSIDAD CATÓLICA DE VALENCIA SAN VICENTE MÁRTIR   (Spain)

^d Mediterranean Ophthalmology Foundation   (Spain)

^e HOSPITAL UNIVERSITARIO LA FE   (Spain)

^f UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

^g Clinica Oftalmologica Centro Caracas   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; HGF PROTEIN, HUMAN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETINITIS PIGMENTOSA; VISUAL ACUITY; VISUAL FIELD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ELECTRORETINOGRAPHY; METABOLISM; MIDDLE AGED;

ADULT; AGED; AQUEOUS HUMOR; ELECTRORETINOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; VISUAL ACUITY;

EID: 77953244396     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4390     Document Type: Article

References (31)

1. Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J Hum Genet. 1980;32:223-235.
2. Humayun MS, Prince M, de Juan E, et al. Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1999;40:143-148.
3. Marigo V. Programmed cell death in retinal degeneration: targeting apoptosis in photoreceptors as potential therapy for retinal degeneration. Cell Cycle. 2007;6:652-655.
4. Russell WE, McGowan JA, Bucher NL. Biological properties of a Hepatocyte growth factor from rat platelets. J Cell Physiol. 1984; 119:193-197.
5. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature. 1989;342: 440-443.
6. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet. 1995;345:293-295.
7. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol. 1995;129:1177-1180.
8. Bussolino F, Di Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992;119:629-641.
9. Hayashi S, Morishita R, Higaki J, et al. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem Biophys Res Commun. 1996;220: 539- 545.
10. Matsumoto K, Nakamura T. Emerging multipotent aspects of he-patocyte growth factor. J Biochem. 1996;119:591-600.
11. Jung W, Castren E, Odenthal M, et al. Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain. J Cell Biol. 1994;126:485-494.
12. Honda S, Kagoshima M, Wanaka A, Tohyama M, Matsumoto K, Nakamura T. Localization and functional coupling of HGF and c-met/HGF receptor in rat brain: implication as neurotrophic factor. Brain Res Mol Brain Res. 1995;32:197-210.
13. Yamagata T, Muroya K, Mukasa T, et al. Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. Biochem Biophys Res Commun. 1995;210:231-237.
14. Hamanoue M, Takemoto N, Matsumoto K, Nakamura T, Nakajima K, Kohsaka S. Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J Neurosci Res. 1996;43: 554-564.
15. Shibuki H, Katai N, Kuroiwa S, et al. Expression and neuroprotec-tive effect of hepatocyte growth factor in retinal ischemia-reper-fusion injury. Invest Ophthalmol Vis Sci. 2002;43:528-536.
16. Machida S, Tanaka M, Ishii T, Ohtaka K, Takahashi T, Tazawa Y. Neuroprotective effect of hepatocyte growth factor against pho-toreceptor degeneration in rats. Invest Ophthalmol Vis Sci. 2004; 45:4174-4182.
17. Shahinfar S, Edward DP, Tso MO. A pathologic study of photore-ceptor cell death in retinal photic injury. Curr Eye Res. 1991;10: 47-59.
18. Tso MO, Zhang C, Abler AS, et al. Apoptosis leads to photorecep-tor degeneration in inherited retinal dystrophy of RCS rats. Invest Ophthalmol Vis Sci. 1994;35:2693-2699.
19. Maulik G, Shrikhande A, Kijima T, Ma PC, Morrison PT, Salgia R. Role of the hepatocyte growth factor receptor, c-met, in oncogen-esis and potential for therapeutic inhibition. Cytokine Growth Factor Rev. 2002;13:41-59.
20. Bevan D, Gherardi E, Fan TP, Edwards D, Warn R. Diverse and potent activities of HGF/SF in skin wound repair. J Pathol. 2004; 203:831-838.
21. Lashkari K, Hirose T, Yazdany J, McMeel JW, Kazlauskas A, Rahimi N. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol. 2000;156:1337-1344.
22. Colombo ES, Menicucci G, McGuire PG, Das A. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression. Invest Ophthalmol Vis Sci. 2007; 48:1793-1800.
23. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. Control Clin Trials. 1999;20:573-600.
24. Schaumberger M, Schafer B, Lachenmayr BJ. Glaucomatous visual fields: FASTPAC versus full threshold strategy of the Humphrey field analyzer. Invest Ophthalmol Vis Sci. 1995;36:1390-1397.
25. Flanagan JG, Moss ID, Wild JM, et al. Evaluation of FASTPAC: a new strategy for threshold estimation with the Humphrey field analyzer. Graefes Arch Clin Exp Ophthalmol. 1993;231:465-469.
26. Marmor MF, Hood DC, Keating D, et al. International Society for Clinical Electrophysiology of Vision: guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol. 2003;106:105- 115.
27. Salom D, Diaz-Llopis M, García-Delpech S, Udaondo P, Sancho-Tello M, Romero FJ. Aqueous humor levels of vascular endothelial growth factor in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2008;49:3499-3502.
28. Nishijima K, Ng YS, Zhong L, et al. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neu-roprotectant during the adaptive response to ischemic injury. Am J Pathol. 2007;171:53-67.
29. Umeda N, Ozaki H, Hayashi H, Kondo H, Uchida H, Oshima K. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonan-giogenic fibroproliferation. Ophthalmic Res. 2002;34:43-47.
30. Hernandez C, Carrasco E, García-Arumí J, Maria Segura R, Simó R. Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy. Diabetes Metab. 2004;30: 341-346.
31. Chu R, Zheng X, Chen D, Hu DN. Blue light irradiation inhibits the production of HGF by human retinal pigment epithelium cells in vitro. Photochem Photobiol. 2006;82:1247-1250.